Kodu・Aktsiate loetelu・Zoetis Inc

Zoetis Inc

Suletud

SektorTervishoid

75.98 -1.43

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

76.83

Max

79.78

Põhinäitajad
By Trading Economics
Sissetulek	-2M 601M
Müük	-125M 2.3B
P/E Sektori keskmine	12.61 64.641
Aktsiakasum	1.53
Dividenditootlus	2.69
Kasumimarginaal	26.569
Töötajad	14,500
EBITDA	-8M 939M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+28.58% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	2.69% 2.31%
Järgmine tulemuste avaldamine	6. aug 2026
Järgmine dividendimakse kuupäev	1. sept 2026
Järgmine aktsia dividendi kuupäev (ex-date)	30. okt 2026

Turustatistika
By TradingEconomics
Turukapital	-16B 32B
Eelmine avamishind	77.41
Eelmine sulgemishind	75.98

Uudiste sentiment

By Acuity

43%

57%

135 / 340 Pingereas Healthcare

Zoetis Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. aug 2026, 23:31 UTC

Zoetis Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains amid favorable market sentiment.

1. aug 2026, 00:01 UTC

Zoetis Inc shares rose in after-market trading, recovering from an initial dip and reaching a high near the upper end of its one-month range.

31. juuli 2026, 23:06 UTC

Zoetis Inc shares are higher in after-market trading, maintaining gains since Friday's close and remaining above the 20-day moving average.

30. juuli 2026, 19:03 UTC

Zoetis Inc shares are lower, impacted by a decline in the Pharmaceuticals sub-sector. Earlier in the session, the stock peaked before falling.

29. juuli 2026, 22:51 UTC

Zoetis Inc shares are trading lower in after-market hours. No specific news was identified to explain the decline amid broader market volatility.

28. juuli 2026, 23:02 UTC

Zoetis Inc shares are higher in after-market trading, reflecting broader market strength amid investor optimism ahead of key earnings reports and the Federal Reserve meeting.

27. juuli 2026, 23:16 UTC

News

Zoetis shares are lower in after-market hours following a class action lawsuit alleging securities fraud and reduced profit guidance to between $6.85 and $7.00 per share.

25. juuli 2026, 00:01 UTC

Zoetis Inc. shares are trading higher in after-market hours, continuing a positive trend after closing higher for three consecutive sessions.

24. juuli 2026, 21:02 UTC

Zoetis Inc shares are higher in after-market trading, rebounding from an initial dip despite a broader market decline influenced by disappointing earnings from Tesla and Alphabet.

23. juuli 2026, 20:02 UTC

Zoetis Inc. shares are higher as strength in the pharmaceuticals sub-sector drives upward momentum, contributing to modest gains since Wednesday's close.

22. juuli 2026, 21:02 UTC

Zoetis Inc. shares are lower in after-market trading, continuing a trend of five consecutive daily declines amid mixed market performance and rising crude oil prices.

21. juuli 2026, 17:51 UTC

News

Zoetis Inc. shares are lower amid scrutiny from a securities fraud class action lawsuit alleging undisclosed market share declines and safety issues with Librela.

20. juuli 2026, 23:16 UTC

Zoetis shares traded higher in after-market hours, maintaining stability above Monday's close despite broader market pressures from rising treasury yields.

Võrdlus sarnastega

Hinnamuutus

Zoetis Inc Prognoos

Hinnasiht

By TipRanks

28.58% tõus

12 kuu keskmine prognoos

Keskmine 99.38 USD 28.58%

Kõrge 130 USD

Madal 85 USD

Põhineb 12 Wall Streeti analüütiku instrumendi Zoetis Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

Osta

Hoia

Müü

Põhineb 12 analüütiku instrumendi Zoetis Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

135 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.